A phase 1 study of PF-06840003, an oral indoleamine 2,3-dioxygenase 1 (IDO1) inhibitor in patients with recurrent malignant glioma
Reardon, David A., Desjardins, Annick, Rixe, Olivier, Cloughesy, Timothy, Alekar, Shilpa, Williams, Jason H., Li, Ray, Taylor, Carrie Turich, Lassman, Andrew B.
Published in Investigational new drugs (01.12.2020)
Published in Investigational new drugs (01.12.2020)
Get full text
Journal Article
Phase II trial of the anti-CD19 bispecific T cell-engager blinatumomab shows hematologic and molecular remissions in patients with relapsed or refractory B-precursor acute lymphoblastic leukemia
Topp, Max S, Gökbuget, Nicola, Zugmaier, Gerhard, Klappers, Petra, Stelljes, Matthias, Neumann, Svenja, Viardot, Andreas, Marks, Reinhard, Diedrich, Helmut, Faul, Christoph, Reichle, Albrecht, Horst, Heinz-August, Brüggemann, Monika, Wessiepe, Dorothea, Holland, Chris, Alekar, Shilpa, Mergen, Noemi, Einsele, Hermann, Hoelzer, Dieter, Bargou, Ralf C
Published in Journal of clinical oncology (20.12.2014)
Published in Journal of clinical oncology (20.12.2014)
Get full text
Journal Article
Bispecific Antibodies in the Treatment of Hematologic Malignancies
Duell, Johannes, Lammers, Philip E., Djuretic, Ivana, Chunyk, Allison G., Alekar, Shilpa, Jacobs, Ira, Gill, Saar
Published in Clinical pharmacology and therapeutics (01.10.2019)
Published in Clinical pharmacology and therapeutics (01.10.2019)
Get full text
Journal Article
First-in-Human Study of PF-06647020 (Cofetuzumab Pelidotin), an Antibody-Drug Conjugate Targeting Protein Tyrosine Kinase 7, in Advanced Solid Tumors
Maitland, Michael L, Sachdev, Jasgit C, Sharma, Manish R, Moreno, Victor, Boni, Valentina, Kummar, Shivaani, Stringer-Reasor, Erica, Lakhani, Nehal, Moreau, Allison R, Xuan, Dawei, Li, Ray, Powell, Eric L, Jackson-Fisher, Amy, Bowers, Michelle, Alekar, Shilpa, Xin, Xiaohua, Tolcher, Anthony W, Calvo, Emiliano
Published in Clinical cancer research (15.08.2021)
Published in Clinical cancer research (15.08.2021)
Get full text
Journal Article
ATIM-29. A PHASE 1 STUDY OF PF-06840003, AN ORAL INDOLE 2,3-DIOXYGENASE 1 (IDO1) INHIBITOR IN PATIENTS WITH MALIGNANT GLIOMAS
Reardon, David, Desjardins, Annick, Rixe, Olivier, Cloughesy, Timothy, Alekar, Shilpa, Gamelin, Erick, Williams, Jason, Meissen, John, Taylor, Carrie, Lassman, Andrew
Published in Neuro-oncology (Charlottesville, Va.) (06.11.2017)
Published in Neuro-oncology (Charlottesville, Va.) (06.11.2017)
Get full text
Journal Article
Incidence Of Comorbidities In Medicare Beneficiaries Diagnosed With Acute Lymphoblastic Leukemia
Cetin, Kara, Danese, Mark, Katz, Aaron J, Kelsh, Michael A, Gleeson, Michelle, Alekar, Shilpa S., Griffiths, Robert
Published in Blood (15.11.2013)
Published in Blood (15.11.2013)
Get full text
Journal Article